SAO PAULO (Reuters) – Brazil’s health regulator Anvisa in a statement on Wednesday set the requirements for approving COVID-19 vaccines for emergency use in the country.
Anvisa said vaccine authorizations would be analyzed case-by-case and producers should still seek usual registration for the vaccines. To gain emergency approval, all vaccines must be in phase 3 of trials, Anvisa said.
(Reporting by Ricardo Brito, writing by Carolina Mandl)
